Colorectal Cancer Clinical Trials

Showing 781-800 of 1,434 trials

Comparison of Adenoma Detection Rate With ENDOCUFF VISION® vs. G-EYE®

NCT04708951

The study is intended to compare the detection rate obtained by performing G-EYE® high definition colonoscopy vs. the detection rate obtained by performing ECV high definition colonoscopy.

AdenomaColorectal Cancer

Dr. Horst Schmidt Klinik GmbH970 participantsStarted Jan 2021

Indianapolis, Indiana, United States • New York, New York, United States • Wiesbaden, Germany

UNKNOWNPHASE2

A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOx

NCT05068206

A clinical study to compare the efficacy and safety of AK105 plus anlotinib and Capecitabine/Oxaliplatin (CapeOx) , anlotinib plus CapeOx, bevacizumab plus CapeOx. A total of 120 cases will be enrolled to the group.

Unresectable Metastatic Colorectal Cancer

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.120 participantsStarted Oct 2021

Lanzhou, Gansu, China • Guangzhou, Guangdong, China • Guangzhou, Guangdong, China +10 more locations

Comparison of Adenoma Detection Rate With ENDOCUFF VISION® vs. G-EYE®

A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOx

Related Searches

Gut Microbiome and Its Immune Modulation in Locally Advanced Rectal Cancer

PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer

Systemic Therapy Sequenced Isolated PALND for mCRC

Transcriptomic Study of IBD-associated Colorectal Cancer

Role of Circulating Tumour DNA Testing in Assessing for Alterations of Primary Anti-EGFR Resistance in RAS/RAF Wild-type Metastatic Colorectal Cancer Patients

Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer

The Relationship Between Fat Free Mass and Toxicity of Cytostatics in Cancer Patients

Outreach and Choice in Colorectal Cancer Screening

Cd133+ Cell Infusion in Patients With Colorectal Liver Metastases.

Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence

Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers

Special Combination of BBI608 and Pembrolizumab

The Impact of Transanal Decompression Tube Placement After Colorectal Anastomosis: A Randomized Trial

Local Wound Infiltration With 0.5% Levobupivacaine for Postoperative Pain After Laparoscopic Colorectal Surgery.

Patients' Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study

The Combination of Fruquintinib, Tislelizumab and Stereotactic Ablative Radiotherapy in Metastatic Colorectal Cancer(RIFLE)

Safety Study of 90Y-hMN14 to Treat Colorectal Cancer

A Phase II Study of IMMU 130 in Patients With Metastatic Colorectal Cancer